Literature DB >> 29403085

Tumor budding as a standardized parameter in gastrointestinal carcinomas: more than just the colon.

Kyra B Berg1, David F Schaeffer2,3.   

Abstract

Tumor budding, defined as single cells or clusters of less than five cells, is thought to be a histomorphologic marker of an aggressive tumor behavior mimicking the embryologic epithelial-mesenchymal transition, and has been well established in the past two decades as a poor prognostic factor in colorectal carcinoma. Slow uptake in routine reporting of this important pathologic prognostic feature was in part due to differing methods of assessment of budding reported in the literature, but has recently been clarified at a consensus conference on tumor budding in colorectal carcinoma. Tumor budding is also increasingly being reported as a useful pathologic prognostic feature in other gastrointestinal carcinomas, including esophageal squamous cell carcinoma and adenocarcinoma, gastric intestinal-type adenocarcinoma, pancreatic ductal adenocarcinoma, and ampullary adenocarcinoma. In this review, we will summarize the studies on tumor budding in gastrointestinal carcinomas, with a focus on the methods of assessment used and the potential clinical applications of the findings.

Entities:  

Mesh:

Year:  2018        PMID: 29403085     DOI: 10.1038/s41379-018-0028-4

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  12 in total

Review 1.  Tumour budding in solid cancers.

Authors:  Alessandro Lugli; Inti Zlobec; Martin D Berger; Richard Kirsch; Iris D Nagtegaal
Journal:  Nat Rev Clin Oncol       Date:  2020-09-08       Impact factor: 66.675

2.  Elevated ZBTB7A expression in the tumor invasive front correlates with more tumor budding formation in gastric adenocarcinoma.

Authors:  Yujing Sun; Junyi He; Duan-Bo Shi; Hui Zhang; Xu Chen; Ai-Yan Xing; Peng Gao
Journal:  J Cancer Res Clin Oncol       Date:  2020-09-23       Impact factor: 4.553

3.  Reproducibility of tumor budding assessment in pancreatic cancer based on a multicenter interobserver study.

Authors:  Eva Karamitopoulou; Irene Esposito; Inti Zlobec; Andrea Cacciato Insilla; Martin Wartenberg; David F Schaeffer; Steve Kalloger; Stefano La Rosa; Christine Sempoux; Irene Ramos Centeno; Philipp Lohneis
Journal:  Virchows Arch       Date:  2020-12-17       Impact factor: 4.064

4.  Towards developing a meaningful grading system for cervical squamous cell carcinoma.

Authors:  W Glenn McCluggage
Journal:  J Pathol Clin Res       Date:  2018-03-30

Review 5.  Tumour budding and its clinical implications in gastrointestinal cancers.

Authors:  Inti Zlobec; Martin D Berger; Alessandro Lugli
Journal:  Br J Cancer       Date:  2020-06-30       Impact factor: 7.640

6.  Association Between Obesity and Histological Tumor Budding in Patients With Nonmetastatic Colon Cancer.

Authors:  Tong Gan; Kurt B Schaberg; Daheng He; Akila Mansour; Harit Kapoor; Chi Wang; B Mark Evers; Therese J Bocklage
Journal:  JAMA Netw Open       Date:  2021-04-01

7.  Clinicopathologic correlations of superficial esophageal adenocarcinoma in endoscopic submucosal dissection specimens.

Authors:  Sadhna Dhingra; Firas Bahdi; Sarah B May; Mohamed O Othman
Journal:  Diagn Pathol       Date:  2021-11-27       Impact factor: 2.644

Review 8.  Intraepithelial tumour infiltrating lymphocytes are associated with absence of tumour budding and immature/myxoid desmoplastic reaction, and with better recurrence-free survival in stages I-III colorectal cancer.

Authors:  I A González; P S Bauer; J Liu; D Chatterjee
Journal:  Histopathology       Date:  2020-09-14       Impact factor: 5.087

Review 9.  Is there still a place for conventional histopathology in the age of molecular medicine? Laurén classification, inflammatory infiltration and other current topics in gastric cancer diagnosis and prognosis.

Authors:  Cristina Díaz Del Arco; Luis Ortega Medina; Lourdes Estrada Muñoz; Soledad García Gómez de Las Heras; Mª Jesús Fernández Aceñero
Journal:  Histol Histopathol       Date:  2021-02-10       Impact factor: 2.303

10.  PRDM3 attenuates pancreatitis and pancreatic tumorigenesis by regulating inflammatory response.

Authors:  Jie Ye; Anpei Huang; Haitao Wang; Anni M Y Zhang; Xiaojun Huang; Qingping Lan; Tomohiko Sato; Susumu Goyama; Mineo Kurokawa; Chuxia Deng; Maike Sander; David F Schaeffer; Wen Li; Janel L Kopp; Ruiyu Xie
Journal:  Cell Death Dis       Date:  2020-03-16       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.